Research Topic · Peer-Reviewed

Diabetes Clinical Trials

Diabetes clinical trials are systematically designed research studies that evaluate the safety, efficacy, and effects of new treatments, devices, and interventions for the prevention and management of diabetes. They follow structured protocols and phases, often involving randomization and controls, to determine whet…

Curated from this journal's research 📚 3 peer-reviewed articles cited Cited 99× across the literature 🔖 ISSN 2374-9431 🗓 Reviewed July 2026

Overview

Diabetes clinical trials are systematically designed research studies that evaluate the safety, efficacy, and effects of new treatments, devices, and interventions for the prevention and management of diabetes. They follow structured protocols and phases, often involving randomization and controls, to determine whether a therapy improves outcomes such as blood glucose control, complication rates, and quality of life compared with existing approaches. Such trials are essential to advancing diabetes care, generating the evidence needed to bring new medications, monitoring technologies, and lifestyle or dietary interventions into clinical practice. They also deepen understanding of the causes, progression, and consequences of diabetes, a chronic metabolic disorder marked by elevated blood glucose. Within the journal's combined focus on Bioinformatics And Diabetes, clinical research connects experimental and computational insights to patient outcomes. Research relevant to this broad scope includes a study on the clinical application of bitter melon for reducing blood sugar in type 2 diabetes, which evaluates an intervention in people with the disease, and work on non-invasive continuous blood glucose measurement techniques, which addresses the monitoring technologies central to diabetes management and trial endpoints. By rigorously testing interventions and tools, this body of work supports the development of better diabetes therapies. This page gathers peer-reviewed, open-access research relevant to diabetes, clinical research, and metabolic disease.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 99 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Diabetes Clinical Trials, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Bioinformatics And Diabetes (ISSN 2374-9431).

Journal editorial board
Wei Wang · United States Chol Hee Jung · Australia Emile Chimusa · United Kingdom

This page summarises published research for orientation; it is not medical or professional advice.